Pharmaceutical and biotechnology companies are working on a record number of medicines for diseases affecting women, according to a new report.
Details of a new report by Pharmaceutical Research and Manufacturers of America in Women’s Health Weekly show that there are 969 new medicines in development.
This includes 112 new treatments for breast cancer and 86 new treatments for obstetric and gynaecologic conditions.
The medicines are awaiting approval from the US Food and Drug Administration or are in human clinical trials.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData